-+ 0.00%
-+ 0.00%
-+ 0.00%

United Therapeutics CEO Martine Rothblatt reports disposal of 9,406 common shares worth $4.64 million

PUBT·09/03/2026 20:32:45
Listen to the news
United Therapeutics CEO Martine Rothblatt reports disposal of 9,406 common shares worth $4.64 million
  • United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at USD 135.42 on Sept. 2, 2026.
  • The trust sold 8,496 shares on the same day at weighted-average prices ranging from USD 477.7 to USD 510.05.
  • Trust holdings ended at 324,443 shares following the reported transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000134), on September 03, 2026, and is solely responsible for the information contained therein.